000 01141 a2200349 4500
005 20250511130259.0
264 0 _c19780628
008 197806s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/BF00606683
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKlotz, U
245 0 0 _aDisposition of valproic acid in patients with liver disease.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cMar 1978
300 _a55-60 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBiological Availability
650 0 4 _aHalf-Life
650 0 4 _aHepatitis
_xmetabolism
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aLiver Cirrhosis, Alcoholic
_xmetabolism
650 0 4 _aLiver Diseases
_xmetabolism
650 0 4 _aMiddle Aged
650 0 4 _aValerates
_xmetabolism
650 0 4 _aValproic Acid
_xmetabolism
700 1 _aRapp, T
700 1 _aMüller, W A
773 0 _tEuropean journal of clinical pharmacology
_gvol. 13
_gno. 1
_gp. 55-60
856 4 0 _uhttps://doi.org/10.1007/BF00606683
_zAvailable from publisher's website
999 _c369851
_d369851